Genetics of amyotrophic lateral sclerosis

Zhurnal Nevropatolgii i Psikhiatrii im. S S Korsakova

Volumn 101, Issue 3, 2001, Pages 54-63

  Andersen, P M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ATROPHY; CASE REPORT; CHROMOSOME 21; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PARESIS; PATHOLOGY; PATHOPHYSIOLOGY; POINT MUTATION; REVIEW; SKELETAL MUSCLE;

AMYOTROPHIC LATERAL SCLEROSIS; ATROPHY; CHROMOSOMES, HUMAN, PAIR 21; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PARESIS; POINT MUTATION; SUPEROXIDE DISMUTASE;

EID: 0035235882     PISSN: 00444588     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (155)

1. Abe K, Aoki M, Ikeda M, Watanabe M, Hirai S, Itoyama Y. Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn superoxide dismutase gene mutations. J Neurol Sci 1996; 136: 108-116.
2. Al-Chalabi A, Enayat ZE, Bakker MC. et al. Association of apolipoprotein E ε4 allele with bulbar-onset motor neuron disease. Lancet 1996; 347: 159-160.
3. Al-Chalabi A, Andersen PM, Chioza B. et al. Receissive amyotrophic lateral sclerosis with the D90A SOD1 mutation shares a common founder: evidence for a linked protective factor. Hum Mol Genet 1998; 13: 2045-2050.
4. Al-Chalabi A, Andersen PM, Nilsson P. et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet 1999; 8: 157-164.
5. Alter M, Shaumann B. A Family with Amyotrophic Lateral Sclerosis and Parkinsonism. J Neurol 1976; 212: 281-284.
6. Amick LD, Nelson JW, Zellweger H. Familial motor neuron disease, non-chamorro type: report of kinship. Acta Neurol Scand 1971; 47: 341-349.
7. Andersen PM, Nilsson P, Ala-Hurula V. et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat Genet 1995; 10: 61-66.
8. Andersen PM, Forsgren L, Binzer M. et al. Autosomal recessive adult-onset ALS associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain 1996; 119: 1153-1172.
9. Andersen PM, Nilsson P, Keränen M-L. et al. Phenotypic heterogeneity in MND-patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 1997; 10: 1723-1737.
10. Andersen PM. Amyotrophic Lateral Sclerosis and CuZn-Superoxide Dismutase. A clinical, genetic and enzymatic study. Doctoral thesis Umeå University: Umeå, Sweden 1997.
11. Andrew SE, Goldberg YP, Hayden MR. Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum Mol Genet 1997; 12: 2005-2010.
12. Aoki M, Lin Cl, Rothstein JD. et al. Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis. Ann Neurol 1998; 5: 645-653.
13. Appel SH. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism and Alzheimer's disease. Ann Neurol 1981; 10: 499-505.
14. Appelbaum JS, Roos RP, Salazar-Grueso EF. et al. Intrafamilial heterogeneity in heriditary motor neuron disease. Neurology 1992; 42: 1488-1492.
15. Aran FA. Researches sur une maladie non encore décrite du système musculaire (atrophie musculaire progressive). Arch Gén Méd 1850; 24: 5-35; 172-214.
16. Banerjee P, Siciliano L, Oliveri D. et al. Molecular basis of an adult form of beta-hexosaminidase B deficiency with motor neuron disease. Biochem Biophys Res Commun 1991; 1: 108-115.
17. Bernhardt M. Ueber eine heriditure form der progressiven spinalen mit bulbärparalyse complicirten muskelatrophie. Virchows Arch f Path Anat Physiol 1889; 115: 197-216.
18. Bobowick AR, Brody JA. Epidemiology of motor-neuron diseases. N Engl J Med 1973; 288: 1047-1055.
19. Borgaonkar DS, Schmidt LC, Martin SE. et al. Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19. Lancet 1993; 8871:625
20. Boukaftane Y, Khoris J, Moulard B. et al. Identification of Six Novel SOD1 Gene Mutations in Familial Amyotrophic Lateral Sclerosis. Canad J Neurol Sci 1998; 25: 192-196.
21. Bowling AC, Schulz JB, Brown RH, Beal MF. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993; 61: 2322-2325.
22. Bowling AC, Barkowski EE, McKenna-Yasek D. et al. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis. J Neurochem 1995; 64: 2366-2369.
23. Brahe C, Servidei S, Zappata S, Ricci E, Tonali P, Neri G. Genetic homogeneity between childhood-onset and adult-onset autosomal recessive spinal muscular atrophy. Lancet 1995; 346: 741-742.
24. Brait K, Fahn S, Schwarz GA. Sporadic and familial parkinsonism and motor neuron disease. Neurology 1973; 23: 990-1002.
25. Brown MR. «Wetherbee Ail»: The inheritance of progressive muscular atrophy as a dominant trait in two New England families. N Engl J Med 1951; 245: 645.
26. Browne SE, Bowling AC, Baik MJ, Gurney M, Brown RH Jr, Beal MF. Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis. J Neurochem 1998; 1: 281-287.
27. Bruijn LI, Becher MW, Lee MK. et al, ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997; 18: 327-338.
28. Burnstein MH, Ananth J. Amyotrophic lateral sclerosis, dementia and psychosis: report of a family and discussion. Psychiat J Univ Ottawa 1980; 3: 166-167.
29. Carpenter S. Proximal axonal enlargement in motor neuron disease. Neurology 1968; 9: 841-851.
30. Cashman NR, Antel JP, Hancock L W. et al. N-acetyl-beta-hexosaminidase bela locus defect and juvenile motor neuron disease: a case study. Ann Neurol 1986; 6: 568-572.
31. Chance PF, Rabin BA, Ryan SG. et al. Linkage of the gene for an autosomal dominant form of juvenile amuotrophic lateral sclerosis to chromosome 9q34. Am J Hum Genet 1998; 3: 633-640.
32. Charcot J-M. Lecons sur les maladies du système nerveux. IInd series, collected by Bourneville 1873. Charcot J-M. Lectures on the Diseases of the Nervous System, vol. 2, series 2, Sigerson G (trans and ed). London: New Sydenham Society, 1881: 163-204.
33. Chio A, Brignolio F, Meineri P, Schiffer D. Phenotypic and genotypic heterogeneity of dominantly inherited amyotrophic lateral sclerosis. Acta Neurol Scand 1987; 75: 277-282.
34. Comi GP, Bordoni A, Salani S. et al. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann Neurol 1998; 43: 110-116.
35. Corder EH, Saunders AM, Strittmatter WJ. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 5123: 921-923.
36. Cudkowicz ME, McKenna-Vasek D, Sapp PE. et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 1997; 2: 210-221.
37. Cudkowicz ME, McKenna-Yasek D, Chen C. et al. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the Cu/Zn superoxide dismutase gene. Ann Neurol 1998; 6: 703-710.
38. Emery AEH, Holloway S. Familial Motor Neuron Diseases: In: Rowland LP (ed.). Human Motor Neuron Diseases. New York: Raven Press 1982; 139-145
39. Engel WK, Kurland LT, Klatzo I. An inherited disease similar to amyotrophic lateral sclerosis with a pattern of posterior column involvement. An intermediate form? Brain 1959; 82: 203-220.
40. Figkwicz DA, Krizus A, Martinoli MG. et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 1757-1761.
41. Finlayson MH, Guberman A, Martin JB. Cerebral lesions in familial amyotrophic lateral sclerosis and dementia. Acta Neuropathol 1973; 26: 237-246.
42. Fong KY, Yu YL, Chan YW. et al. Motor neuron disease in Hong Kong Chinese: Epidemiology and clinical picture. Neuroepidemiology 1996; 15: 239-245.
43. Forman HJ, Fridovich I. On the stability of bovine superoxide dismutase. The effects of metals. J Biol Chem 1973; 248: 2645-2649
44. Forsgren L, Almay BGL, Holmgren G, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand 1983; 68: 20-29.
45. Gajdusek DC. Motor-neuron disease in natives of New Guinea. N Engl J Med 1963; 268: 474-476.
46. Gardner JH, Feldmahn A. Heriditary adult motor neuron disease. Trans Am Neurol Ass 1966; 91: 239-241.
47. Garruto RM, Yanagihara R, Gajdusek DC. Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Neurology 1985; 2: 193-198.
48. Giess R, Goetz R, Schrank B, Ochs G, Sendtner M, Toyka K. Potential implications of a ciliary neurotrophic factor gene mutation in a German population of patients with motor neuron disease. Muscle Nerve 1998; 21: 236-238.
49. Gunnarsson L-G, Dahlbom K, Strandman E. Motor neuron disease and dementia reported among 13 members of a single family. Acta Neurol Scand 1991; 84: 429-433.
50. Haberlandt WF. Genetic aspects of amyotrophic lateral sclerosis and progressive bulbar paralysis. Acta Genet Med Gemell 1959; 8: 369-373.
51. Hamida MB, Hentati F, Hamida CB. Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Brain 1990; 113: 347-363.
52. Hamilton AS. Familial progressive muscular atrophy in adults. J Nerv Ment Dis 1918; 48: 127-150.
53. Hancock LW, Horwitz AL, Cashman NR, Antel JP, Dawson G. N-acetyl-beta-hexosaminidase B defiency in cultured fibroblasts from a patient with progressive motor neuron disease. Biochem Biophys Res Commun 1985; 3: 1185-1192.
54. Haverkamp LJ, Appel V, Appel SH. Natural History of amyotrophic lateral sclerosis in a database population. Brain 1995; 118: 707-719.
55. Hawks CH, Graham AJ. National UK motor neuron disease twin study using the death discordant approach. Ann Neurol 1992; 32: 272-273.
56. Hayward C, Colville S, Swingler RJ, Brock DJH. Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis. Neurology 1999; 52: 1899-1901.
57. Hentati A, Bejaoui K, Pericak-Vance MA. et al. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. Nat Genet 1994; 7: 425-428.
58. Hentati A, Ouahchi K, Pericak-Vance MA. et al. Linkage of a common locus for recessive amyotrophic lateral sclerosis (abst). Am J Hum Genet 1997; 61(Suppl): A279.
59. Hestnes A, Mellgren SI. Familial amyotrophic lateral sclerosis. Acta Neurol Scand 1980; 61: 192-199.
60. Hirano A, Kurland LT, Sayre GP. Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch Neurol 1967; 16: 232-243.
61. Hirano A, Donnefeld H, Sasaki S, Nakano I. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1984; 43: 461-470.
62. Hirano A, Nakano I, Kurland LT. et al. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1984; 43: 471-480.
63. Hojer-Pedersen E, Christensen PB, Jensen NB. Incidence and prevalence of motor neuron disease in two Danish counties. Neuroepidemiology 1989; 8: 151-159.
64. Hosler BA, Sapp PC, Berger R. et al. Refined mapping and characterization of the recessive familial amyotrophic lateral sclerosis locus (ALS2) on chromosome 2q33. Neurogenetics 1998; 1: 34-42.
65. Hudson AJ. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurologial disorders: a review. Brain 1981; 104: 217-247.
66. Hurd DD, Saxton WM. Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport in Drosophilia. Genetics 1996; 144: 1075-1085.
67. Husquinet H, Franck G. Hereditary amyotrophic lateral sclerosis transmitted for five generations. Clin Genet 1980; 18: 109-115.
68. Hutton M, Lendon CL, Rizzu P. et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702-705.
69. Ikeda M, Abe K, Aoki M. et al. Variable clinical symptoms in familial amyotrophic lateral sclerosis with a novel point mutation in the CuZn- superoxide dismutase gene. Neurology 1995; 45: 2038-2042.
70. Imura T, Shimohama S, Kawamata J, Kimura J. Genetic variation in the Ciliary Neurotrophic Factor Receptor a gene and familial amyotrophic lateral sclerosis. Ann Neurol 1998; 2: 275.
71. Ince PG, Tomkins J, Slade JY, Thatcher NM, Shaw PJ. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five cases, and comparison with previous reports and 73 sporadic cases of ALS. J Neuropathol Exp Neurol 1998; 10: 895-904.
72. Jablecki CK, Berry C, Leach J. Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve 1989; 12: 833-841.
73. Jackson M, Morrison KE, Al-Chalabi A, Bakker M, Leigh PN. Analysis of Chromosome 5q13 Genes in Amyotrophic Lateral Sclerosis: Homozygous NAIP Deletion in a Sporadic Case. Ann Neurol 1996; 39: 796-800.
74. Jackson M, Al-Chalabi A, Enayat ZE, Chioza B, Leigh PN, Morrison KE. Copper/Zinc Superoxide Dismutase 1 and Sporadic Amyotrophic Lateral Sclerosis: Analysis of 155 Cases and Identification of a Novel Insertion Mutation. Ann Neurol 1997; 42: 803-807.
75. Jokelainen M. Amyotrophic lateral sclerosis in Finland. II: Clinical characteristics. Acta Neurol Scand 1977; 56: 194-204.
76. Jones CT, Swingler RJ, Brock DJH. Identification of a novel SOD1 mutation in an apparantly sporadic amyotrophic lateral sclerosis patient and the detection of Ile113Thr in three others. Hum Mol Genet 1994; 3:4: 649-650.
77. Juneja T, Pericak-Vance MA, LaingNG, Dave S, Siddique T. Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and A4V mutations in CuZn-superoxide dismutase. Neurology 1997; 48: 55-57.
78. Keränen M-L, Ala-Hurula V-M, Saarinen A, Andersen PM, Marklund SL. Familiaalinen amyotrofinen lateraaliskleroosi Pohjois-Suomessa. Duodecim 1996; 112: 2026-2030.
79. Kisby GE, Milne J, Sweet C. Evidence of reduced DN A repair in amyotrophic lateral sclerosis brain tissue. Neuro Report 1997; 8: 1337-1340.
80. Kitada T, Asakawa S, Hattori N. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392: 605-608.
81. Kostrzewa M, Damian MS, Müller U. Superoxide dismutase I: Identification of a novel mutation in a case of familial amyotrophic lateral sclerosis. Hum Genet 1996; 98: 48-50.
82. Kristensen O, Melgaard B. Motor neuron disease. Prognosis and Epidemiology. Acta Neurol Scand 1977; 56: 299-308.
83. Kurland KT, Mulder DW. Epidemiological investigations of amyotrophic lateral sclerosis. Familial aggregations indicative of dominant inheritance. Part 1, II. Neurology 1955; 5: 182-267.
84. Le Coz P, Assouline E, Vanier MT. et al. GM2-Gangliosidosis variant B1 disclosed during adolescence by an isolated multi-systemic involvement of the central and peripheral nervous systems. Rev Neurol (Paris) 1994; 1: 61-66.
85. Lefevre S, Burglen L, Reboullet S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80: 155-165.
86. Li T-M, Alberman E, Swash M. Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease. J Neurol Neurosurg Psychiatry 1988; 51: 778-784.
87. Lin C-LG, Bristol LA, Jin L. et al. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998; 20: 589-602.
88. Mackay RP. Course and prognosis in amyotrophic lateral sclerosis. Arch Neurol 1963; 8: 117-127.
89. Manetto V, Sternberger NH, Perry G. et al. Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1988; 47: 642-653.
90. Masu Y, Wolf E, Holtmann B, Sendtner M, Brem G, Thoenen H. Disruption of the CNTF gene results in motor neuron degeneration. Nature 1993; 365: 27-32.
91. Meyer T, Munch C, Volkel H, Booms P, Ludotph AC. The EAAT2 (GLT-I) gene in motor neuron disease: absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia. J Neurol Neurosurg Psychiat 1998; 4: 594-596.
92. Mitsumoto H, Sliman RJ, Schafer IA. et al. Motor neuron disease and adult hexosaminidase A deficiency in two families: evidence for multisystem degeneration. Ann Neurol 1985; 4: 378-385.
93. Mondelli M, Rossi A, Palmeri S, Rizzuto N, Federico A. Nurophysiological study in chronic GM2 gangliosidosis (hexosaminidase A and B deficiency), with motor neuron disease phenotype. Ital J Neurol Sci 1989; 4: 433-439.
94. Moulard B, Sefiani A, Laamri A, Malafosse A, Camu W. Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis. J Neurol Sci 1996; 139(Suppl): 34-37.
95. Moulard B, Salachas F, Chassande B. et al. Association between centromeric deletions of the SMN gene and sporadic adult-onset lower motor neuron disease. Ann Neurol 1998; 5: 640-644.
96. Mui S, Rebeck GW, McKenna-Yasek D, Hyman BT, Brown RH Apolipoprotein E ε4 Allele Is Not Associated with Earlier Age at Onset in Amyotrophic Lateral Sclerosis. Ann Neurol 1995; 38: 460-463.
97. Mulder DW. Clinical limits of amyotrophic lateral sclerosis. In: Human Motor Neuron Diseases (Ed. Rowland LP). New York: Raven Press 1982.
98. Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motor neuron disease: Amyotrophic lateral sclerosis. Neurology 1986; 36: 511-517.
99. Munoz DG, Greene C, Perl DP, Selkoe DJ. Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients. J Neuropathol Exp Neurol 1988; 47: 9-18.
100. Murros K, Fogelholm R. Amyotrophic lateral sclerosis in middle-Finland: an epidemiological study. Acta Neurol Scand 1983; 67: 41-47.
101. Myrianthopoulos NC, Brown IA. A genetic study of progressive spinal muscular atrophy. Am J Hum Genet 1954; 6: 387-411.
102. Nagai M, Abe K, Okamoto K. et al. Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients. Neurosci Lett 1998; 244: 165-168.
103. Nakano T, Tsukuda N, Yanagisawa N. et al. Familial motor neuron disease with cases of amyotrophic lateral sclerosis and spinal muscular atrophy. Rinsho Shinkeigaku 1985; 25: 1119-1125.
104. Neary D, Snowden JS, Mann DM. et al. Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiat 1990; 53: 23-32.
105. Neilson S, Robinson I, Nymoen EH. Longitudinal analysis of amyotrophic lateral sclerosis mortality in Norway, 1966-1989: evidence for a susceptible subpopulation. J Neurol Sci 1994; 122: 148-154.
106. Neilson S, Gunnarsson LG, Robinson I. Rising mortality from motor neurone disease in Sweden 1961-1990: the relative role of increased population life expectancy and environmental factors. Acta Neurol Scand 1994; 3: 150-159.
107. Norris FH. Adult spinal motor neuron disease. In: Handbook of Clinical Neurology, System Disorders and Atrophies. Eds. Vinken PJ, Bruyn GW. 1975; 22.
108. Olkowski ZL, Mutant AP endonuclease in patients with amyotrophic lateral sclerosis. Neuro Report 1998; 9: 239-242.
109. Orrell RW, Hahgood JJ, Gardiner I. et al. Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurology 1997; 48 746-751.
110. Orrell RW, Habgood JJ, de Belleroche JS, Lane RJ. The relationship of spinal muscular atrophy to motor neuron disease: investigation of SMN and NAIP gene deletions in sporadic and familial ALS. J Neurol Sci 1997; 1: 55-61.
111. Osler W. On heridity in progressive muscular atrophy as illustrated in the Farr family of Vermont. Arch Med 1880; 4: 316-320.
112. Parboosingh JS, Rouleau GA, Meninger V, McKenna-Yasek D, Brown RH, Figlewicz DA. Absence of mutations in the Mn superoxide dismutase or catalase genes in familial amyotrophic lateral sclerosis. Neuromusc Dis 1995; 1: 7-10.
113. Parboosingh JS, Figlewicz DA, Krizus A. et al. Spinobulbar muscular atrophy can mimic ALS: the importance of genetic testing in male patients with atypical ALS. Neurology 1997; 49: 568-572.
114. Parboosingh JS, Meininger V, McKenna-Yasek D, Brown RH Jr, Rouleau G. Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis. Arch Neurol 1999; 56: 710-712.
115. Pardo CA, Xu Z, Borchelt DR. et al. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Nat Acad Sci USA 1995; 92: 954-958.
116. Pinsky L, Finlayson MH, Libman I, Scott BH. Familial amyotrophic lateral sclerosis with dementia - a second Canadian family. Clin Genet 1975; 7: 187.
117. Polymeropoulos MH, Lavedan C, Leroy E. et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 5321: 2045-2047.
118. Radunovic A, Leigh PN. CuZn Superoxide dismtitase gene mutations in ALS. Correlation between genotype and clinical features. J Neurol Neurosurg Psychiat 1996; 61: 565-572.
119. Riggs JE. Longitudinal Gompertzian analysis of amyotrcphic lateral sclerosis mortality in the U.S., 1977-1986. Evidence for an inherently susceptible subset. Mech Ageing Dev 1990; 55: 207.
120. Robberecht W, Aguirre T, Bosch LVD, Tilkin P, Cassiman JJ, Matthijs G. D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology 1996; 47: 1336-1339.
121. Robertson EE. Progressive bulbar paralysis showing heredofamilial incidence and intellectual impairment. Arch Neurol Psychiat 1953; 69: 197-207.
122. Robinson GW. The spinal type and family form of progressive muscular atrophy as appearing in adults. J Nerv Ment Dis. 1917; 45: 401.
123. Rodrigues NR, Owen N, Talbot K. et al. Gene deletions in spinal muscular atrophy. J Med Genet 1996; 2: 93-96.
124. Roe PF. Familial motor neurone disease. J Neurol Neurosurg Psychiat 1964; 27: 140-143.
125. Rooke K. Figlewicz DA, Han FY, Rouleau GA. Analysis of the KSP repeat of the neurofilament heavy subunit in familial amyotrophic lateral sclerosis. Neurology 1996; 46: 789-790.
126. Rosati G, Pinna L, Granieri E, Aiello I, Tola R, Agnetti V. et al. Studies on epidemiological, clinical and etiological aspects of ALS disease in Sardinia, Southern Italy. Acta Neurol Scand 1977; 55: 231-244.
127. Rosen AD. Amyotrophic lateral sclerosis. Clinical features and prognosis. Arch Neurol 1978; 35: 638-642.
128. Rosen DR, Siddique T, Patterson D. et al. Mutations in CuZn superopxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
129. Rouleau GA, Clark A W, Rooke K, Pramatarova A, Krizus A, Suchowersky O. Julien J-P, Figlewicz D. SOD1 mutations is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurol 1996; 39: 128-131.
130. Roy N, Mahadevan MS, McLean M. et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995; 80: 167-178.
131. Rubin M, Karpati G, Wolfe LS, Carpenter S, Klavins MH, Mahuran DJ. Adult onset motor neuronopathy in the juvenile type of hexosaminidase and B deficiency. J Neurol Sci 1988; 1: 103-119.
132. Sapp PC, Rosen DR, Hosler BA. et al. Identification of three novel mutations in the gene for CuZn superoxide dismutase in patients with familial amyotrophic lateral sclerosis. Neuromuscular Dis 1995; 5: 353-357.
133. Schmitt HP, Emser W, Heimes C. Familial occurrence of amyotrophic lateral sclerosis, parkinsonism, and dementia. Ann Neurol 1984; 16: 642-648.
134. Shaw CE, Enayat ZE, Powell JF. et al. Familial amyotrophic lateral sclerosis. Molecular pathology of a patient with a SOD1 mutation. Neurology 1997; 49, 1612-1616.
135. Shaw CE, Enayat ZE, Chioza BA. et al. Mutations in All Five Exons of SOD-1 May Cause ALS. Ann Neurol 1998; 43: 390-394.
136. Shaw PJ, Thagesen H, Tomkins J. et al. Kennedy's disease: unusual molecular pathologic and clinical features. Neurology 1998; 1: 252-255.
137. Shibata N, Hirano A, Kobayashi M. et al. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 1996; 55: 481-490.
138. Siddique T, Figlewicz DA, Pericak-Vance MA. et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med 1991; 324: 1381-1384.
139. Siddique T, Hong ST, Brooks BR. et al. X-linked Dominant locus for late-onset familial amyotrophic lateral sclerosis. Am Soc Hum Genet Meetting 1998; Oct: Abstr 1785.
140. Smith RG, Haverkamp LJ, Case S, Appel V, Appel SH. Apolipoprotein E ε4 in bulbar-onset motor neuron disease. Lancet 1996; 348: 334-335.
141. Strong MJ, Hudson AJ, Alvord WG. Familial amyotrophic lateral sclerosis, 1850-1989: a statistical analysis of the world literature. Canad J Neurol Sci 1991; 18: 45-58.
142. Suthers G, Laing N, Wilton S, Dorosz S, Waddy H «Sporadic» motoneuron disease due to familial SOD1 mutation with low penetrance. Lancet 1994; 344: 1773.
143. Takahashi K, Nakamura H, Okada E. Heriditary amyotrophic lateral sclerosis. Histochemical and electron microscopic studies of hyaline inclusions in motor neurons. Arch Neurol 1972; 27: 292-299.
144. Takahashi R, Yokoji H, Misawa H, Hayashi M, Hu J. Deguchi T. A null mutation in the human CNTF gene is not causally related to neurological diseases. Nat Genet 1994; 7: 79-84.
145. Tandan R, Bradley WG. Amyotrophic lateral sclerosis. Part 1, 2. Ann Neurol 1985; 18: 271-280, 419-431.
146. Thomson AF, Alvarez FA. Hereditary amyotrophic lateral sclerosis. J Neurol Sci 1968; 8: 101-110.
147. Tomblyn M, Kasarskis EJ, Xu Y, St Clair DK. Distribution of MnSOD polymorphisms in sporadic ALS patients. J Mol Neurosci 1998; 1: 65-66.
148. Tomkins J, Usher P, Slade JY et al. Novel NF-H insertion in ALS. Neuroreport 1998; 9: 3967-3970.
149. Toyoshima I, Sugawara M, Kato K. et al. Kinesin and cytoplasmic dynein in spinal spheroids with motor neuron disease. J Neurol Sci 1998; 1: 38-44.
150. Tu P-H, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, Lee VM-Y. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Nat Acad Sci USA 1996; 93: 3155-3160.
151. Van Landeghem GF, Tabatabaie, Beckman L, Beckman G, Andersen PM. Mn-SOD Signal Sequence Polymorphism Associated with Sporadic Motor Neuron Disease. Eur J Neurol 1999.
152. Vechio JD, Bruijn LI, Xu Z, Brown RH Jr, Cleveland D. Sequence variants in human neurofilament proteins: absence of linkage to familal amyotrophic lateral sclerosis. Ann Neurol 1996; 40: 603-610.
153. Veltema AN, Ross RAC, Bruyn GW. Autosomal dominant adult amyotrophic lasteral sclerosis: a six-generation Dutch family. J Neurol Sci 1990; 97: 93-115.
154. Williams DB, Floate DA, Leicester J. Familial motor neuron disease: differing penetrance in large pedigrees. J Neurol Sci 1988; 86: 215-230.
155. Yoshida S, Uebayashi Y, Kihira T. et al. Epidemiology of motor neuron disease in the Kii Peninsula of Japan, 1989-1993: active or disappearing focus? J Neurol Sci 1998; 2: 146-155.